INSR and metabolic dysfunction-associated steatotic liver disease: Adipocytokine signaling pathway, non-alcoholic fatty liver disease, negative regulation of insulin receptor signaling pathway, type II diabetes mellitus, insulin resistance, negative regulation of inflammatory response, TNF signaling pathway